Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer.

Clark PE, Peereboom DM, Dreicer R, Levin HS, Clark SB, Klein EA
Urology. 2001 57 (2): 281-5

PMID: 11182337 · DOI:10.1016/s0090-4295(00)00914-6

MeSH Terms (13)

Antineoplastic Agents, Hormonal Antineoplastic Agents, Phytogenic Estramustine Etoposide Follow-Up Studies Humans Male Middle Aged Neoadjuvant Therapy Prostate-Specific Antigen Prostatectomy Prostatic Neoplasms Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: